Eli Lilly Acquires Seamless Therapeutics for Hearing Loss Treatment
Eli Lilly's recent stock popularity is largely driven by its obesity drug Zepbound, but the company is also expanding into ...
Eli Lilly's recent stock popularity is largely driven by its obesity drug Zepbound, but the company is also expanding into ...
On December 24, 2025, OrbiMed Advisors LLC, through its Director position at Sionna Therapeutics (NASDAQ:SION), sold 33,356 shares for approximately ...
CRISPR Therapeutics (NASDAQ: CRSP) experienced a significant surge of over 200% from early 2020 to early 2021 due to optimism ...
HighVista Strategies LLC disclosed a new investment in Cidara Therapeutics (NASDAQ: CDTX) in a November 14, 2025 SEC filing, acquiring ...
Summit Therapeutics (NASDAQ: SMMT) is a notable publicly traded company with a market cap exceeding $10 billion, yet it has ...
Vera Therapeutics (NASDAQ: VERA) experienced a notable increase in its stock price, closing 13% higher on Wednesday, following a positive ...
Cidara Therapeutics (NASDAQ: CDTX) saw its stock rise nearly 7% on Friday, significantly outperforming the S&P 500's 0.6% increase, following ...
Shares of clinical-stage biotech CytomX Therapeutics (NASDAQ: CTMX) surged by 43% this week following analyst Olivia Brayer from Cantor Fitzgerald ...
Relay Therapeutics (NASDAQ: RLAY) experienced a nearly 15% increase in its stock price during a holiday-shortened trading week, driven by ...
One day before the July Fourth holiday, shares of clinical-stage biotech Summit Therapeutics (NASDAQ: SMMT) surged by 8% following a ...
Copyright © 2026 News Wave
News Wave is not responsible for the content of external sites.